We are developing new imaging diagnostic drugs and methods that can help resolve the uncertainties in cancer diagnosis and treatment decisions by utilizing novel molecular imaging techniques. We aim to provide a new qualitative diagnosis of cancer that is difficult to achieve with existing methods, and are exploring commercialization to realize more optimized cancer drug therapy.
Kazuhide Sato
Designated Lecturer, Nagoya univ.